Warmth in the Chill: High Velocity Therapy for RSV, COVID, & Flu
Learn how high velocity therapy can benefit your patients in respiratory distress for the winter season.
"Warmth in the Chill: High Velocity Therapy for RSV, COVID, & Flu," an insightful webinar focused on the mechanisms of action and best practices using high velocity therapy to support respiratory distress in pediatric and adult patients. Learn how high velocity therapy can benefit your patients in respiratory distress for the winter season.
Objectives:- Describe updated disease prevalence information that may help a respiratory department prepare for “respiratory season”.
- Describe the mechanisms of action for high velocity therapy.
- Understand the clinical evidence that supports the use of high velocity therapy for hypoxic and hypercapnic respiratory failure for pediatric & adult patient populations.
Respiratory Therapists can earn 1 AARC RT CRCE. Nurses can earn 1 Contact Hour.
Your Instructor
Michael C. McQueen MD, MBA, FAAP, has over 28 years of clinical and leadership experience. He has served as Regional Medical Director for Envision Healthcare, Medical Director of the NICU at Phoenix Children’s Hospital, as well as several NICUs within the Banner Healthcare System in Phoenix. He has also served as Regional President for Pediatrix Medical Group, and President of Obstetrix Medical Group. Dr. McQueen completed his Pediatric Residency at Phoenix Children’s Hospital / Maricopa Medical Center in Phoenix, AZ, and his Neonatal-Perinatal Medicine Fellowship at the University of Vermont, Burlington, VT. His recent contributions on High-Velocity Nasal Insufflation respiratory support in neonates can be found in J Pulm Respir Med (2014), J Health Economics and Outcomes Research (2015), and J Perinatology (2017). Dr. McQueen is currently Vice President of Medical Affairs at Vapotherm, Inc.